Skip to content
ChickenStockChickenStock
ResearchCLBT
Cellebrite Di logo

Cellebrite Di (CLBT) stock

NASDAQ

$11.54+5.92%(+0.64)

As of the Nov 13, 2026 close (U.S. Eastern)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Latest fiscal year

Latest fiscal-year financials · Computed in-house by ChickenStock

P/E

36.82x

P/B

5.93x

P/S

6.03x

Latest earnings

Recent results in a standard quarterly format were not found in SEC filings.

Some foreign companies file only annual or current reports, so quarterly figures may be missing.

See recent SEC filings →

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

19 SEC filings
  • Jewell MarcusGlobal Chief Revenue Officer · Nov 12, 2026Open-market sale393 shares · $5K
    Avg. price $13.3103426,735 shares held after
  • GEE DAVID NICHOLASChief Marketing Officer · Nov 12, 2026Open-market sale234 shares · $3K
    Avg. price $13.3103135,047 shares held after
  • Barter DavidChief Financial Officer · Oct 16, 2026Open-market sale12,134 shares · $136K
    Avg. price $11.2139322,085 shares held after
  • Ramji ShivenChief Executive Officer · Sep 24, 2026Grant or award38,505 shares · $0
    Avg. price $0462,055 shares held after
  • Baudot-Trajtenberg NadineDirector · Sep 17, 2026Grant or award15,190 shares · $0
    Avg. price $050,744 shares held after
  • Richardson TroyDirector · Sep 17, 2026Grant or award15,190 shares · $0
    Avg. price $036,164 shares held after
  • Van Buren BrandonDirector · Sep 17, 2026Grant or award15,190 shares · $0
    Avg. price $050,744 shares held after
  • Gruber DafnaDirector · Sep 17, 2026Grant or award15,190 shares · $0
    Avg. price $043,109 shares held after
  • Domnitz YonatanDirector · Sep 17, 2026Grant or award15,190 shares · $0
    Avg. price $086,586 shares held after
  • CLAMMER ADAMDirector · Sep 17, 2026Grant or award15,190 shares · $0
    Avg. price $086,586 shares held after
  • Utsumi RyusukeDirector · Sep 17, 2026Grant or award15,190 shares · $0
    Avg. price $066,586 shares held after
  • Hogan Thomas E.Insider · Aug 25, 2026Open-market sale25,299 shares · $286K
    Avg. price $11.2934765,249 shares held after
  • GEE DAVID NICHOLASChief Marketing Officer · Aug 24, 2026Open-market sale4,323 shares · $49K
    Avg. price $11.3605135,281 shares held after
  • Jewell MarcusGlobal Chief Revenue Officer · Aug 21, 2026Open-market sale12,562 shares · $141K
    Avg. price $11.2416427,128 shares held after
  • GEE DAVID NICHOLASChief Marketing Officer · Aug 21, 2026Open-market sale2,198 shares · $25K
    Avg. price $11.2416139,604 shares held after
  • Hogan Thomas E.Chief Executive Officer · Aug 12, 2026Open-market sale139,713 shares · $2.1M
    Avg. price $15.3861790,548 shares held after
  • Jewell MarcusGlobal Chief Revenue Officer · Aug 12, 2026Open-market sale411 shares · $7K
    Avg. price $16.0678439,690 shares held after
  • GEE DAVID NICHOLASChief Marketing Officer · Aug 12, 2026Open-market sale230 shares · $4K
    Avg. price $16.0678141,802 shares held after
  • Hogan Thomas E.Chief Executive Officer · Aug 11, 2026Grant or award339,484 shares · $0
    Avg. price $0930,261 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Cellebrite Di (CLBT) stock information

NASDAQ

Cellebrite Di (CLBT) is listed on NASDAQ. Its market capitalization is about $2.9B. On trailing-twelve-month earnings the P/E ratio is 36.82, and the P/B ratio is 5.93. Return on equity is 16.1%. These figures are computed in-house from official filings and are reference information only.

Cellebrite Di — frequently asked questions

What is the P/E ratio of Cellebrite Di (CLBT)?
On a trailing-twelve-month basis, CLBT trades at a P/E ratio of 36.82. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Cellebrite Di?
CLBT has a market capitalization of about $2.9B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.